These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 29518423)

  • 21. The inducible nitric oxide synthase promoter polymorphism does not confer susceptibility to systemic lupus erythematosus.
    López-Nevot MA; Ramal L; Jiménez-Alonso J; Martín J
    Rheumatology (Oxford); 2003 Jan; 42(1):113-6. PubMed ID: 12509623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inducible nitric oxide synthase promoter polymorphism in human brucellosis.
    Orozco G; Sánchez E; López-Nevot MA; Caballero A; Bravo MJ; Morata P; de Dios Colmenero J; Alonso A; Martín J
    Microbes Infect; 2003 Nov; 5(13):1165-9. PubMed ID: 14623011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preliminary evidences of a NOS2A protective effect from relapsing-remitting multiple sclerosis.
    Manna I; Liguori M; Valentino P; Condino F; La Russa A; Clodomiro A; Nisticò R; Di Palma G; Quattrone A
    J Neurol Sci; 2008 Jan; 264(1-2):112-7. PubMed ID: 17854833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inducible but not endothelial nitric oxide synthase polymorphism is associated with susceptibility to rheumatoid arthritis in northwest Spain.
    Gonzalez-Gay MA; Llorca J; Sanchez E; Lopez-Nevot MA; Amoli MM; Garcia-Porrua C; Ollier WE; Martin J
    Rheumatology (Oxford); 2004 Sep; 43(9):1182-5. PubMed ID: 15226517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The CCTTT polymorphism in the NOS2A gene is associated with dementia with Lewy bodies.
    Xu W; Liu L; Emson P; Harrington CR; McKeith IG; Perry RH; Morris CM; Charles IG
    Neuroreport; 2000 Feb; 11(2):297-9. PubMed ID: 10674474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of nitric oxide synthase gene polymorphisms on the risk of cardiovascular events in rheumatoid arthritis.
    Gonzalez-Gay MA; Llorca J; Palomino-Morales R; Gomez-Acebo I; Gonzalez-Juanatey C; Martin J
    Clin Exp Rheumatol; 2009; 27(1):116-9. PubMed ID: 19327239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. iNOS promoter variants and severe malaria in Ghanaian children.
    Cramer JP; Mockenhaupt FP; Ehrhardt S; Burkhardt J; Otchwemah RN; Dietz E; Gellert S; Bienzle U
    Trop Med Int Health; 2004 Oct; 9(10):1074-80. PubMed ID: 15482399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymorphisms in oxidative pathway related genes and susceptibility to inflammatory bowel disease.
    Senhaji N; Nadifi S; Zaid Y; Serrano A; Rodriguez DAL; Serbati N; Karkouri M; Badre W; Martín J
    World J Gastroenterol; 2017 Dec; 23(47):8300-8307. PubMed ID: 29307990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nitric oxide synthase 2 (NOS2) promoter polymorphisms in colorectal cancer.
    Fransén K; Elander N; Söderkvist P
    Cancer Lett; 2005 Jul; 225(1):99-103. PubMed ID: 15922861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased risk of intestinal type of gastric adenocarcinoma in Japanese women associated with long forms of CCTTT pentanucleotide repeat in the inducible nitric oxide synthase promoter.
    Tatemichi M; Sawa T; Gilibert I; Tazawa H; Katoh T; Ohshima H
    Cancer Lett; 2005 Jan; 217(2):197-202. PubMed ID: 15617837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CCTTT pentanucleotide repeats in inducible nitric oxide synthase gene expression in patients with pulmonary arterial hypertension.
    Baloira Villar A; Pousada Fernández G; Vilariño Pombo C; Núñez Fernández M; Cifrián Martínez J; Valverde Pérez D
    Arch Bronconeumol; 2014 Apr; 50(4):141-5. PubMed ID: 24439467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The (CCTTT)n microsatellite polymorphism in the NOS2 gene may influence lung cancer risk and long-term survival, especially in non-smokers.
    Ryk C; Hou SM; Pershagen G; Wiklund NP; Nyberg F; de Verdier PJ
    Tumour Biol; 2014 May; 35(5):4425-34. PubMed ID: 24408018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic determinants of rheumatoid arthritis: the inducible nitric oxide synthase (NOS2) gene promoter polymorphism.
    Pascual M; López-Nevot MA; Cáliz R; Koeleman BP; Balsa A; Pascual-Salcedo D; Martín J
    Genes Immun; 2002 Aug; 3(5):299-301. PubMed ID: 12140750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inducible nitric oxide synthase genetic polymorphism and risk of asbestosis.
    Franko A; Dodič-Fikfak M; Arnerić N; Dolžan V
    J Biomed Biotechnol; 2011; 2011():685870. PubMed ID: 21660141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inducible nitric oxide synthase promoter polymorphism, cigarette smoking, and urothelial carcinoma risk.
    Shen CH; Wang YH; Wang WC; Jou YC; Hsu HS; Hsieh HY; Chiou HY
    Urology; 2007 May; 69(5):1001-6. PubMed ID: 17482959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variants of NOS1, NOS2, and NOS3 genes in asthmatics.
    Gao PS; Kawada H; Kasamatsu T; Mao XQ; Roberts MH; Miyamoto Y; Yoshimura M; Saitoh Y; Yasue H; Nakao K; Adra CN; Kun JF; Moro-oka S; Inoko H; Ho LP; Shirakawa T; Hopkin JM
    Biochem Biophys Res Commun; 2000 Jan; 267(3):761-3. PubMed ID: 10673365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytosolic phospholipase A2 group IVA is overexpressed in patients with persistent asthma and regulated by the promoter microsatellites.
    Sokolowska M; Stefanska J; Wodz-Naskiewicz K; Cieslak M; Pawliczak R
    J Allergy Clin Immunol; 2010 Jun; 125(6):1393-5. PubMed ID: 20392485
    [No Abstract]   [Full Text] [Related]  

  • 38. Functional variants in NOS1 and NOS2A are not associated with progressive hearing loss in Ménière's disease in a European Caucasian population.
    Gazquez I; Lopez-Escamez JA; Moreno A; Campbell CA; Meyer NC; Carey JP; Minor LB; Gantz BJ; Hansen MR; Della Santina CC; Aran I; Soto-Varela A; Santos S; Batuecas A; Perez-Garrigues H; Lopez-Nevot A; Smith RJ; Lopez-Nevot MA
    DNA Cell Biol; 2011 Sep; 30(9):699-708. PubMed ID: 21612410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NOS2 polymorphisms associated with the susceptibility to pulmonary arterial hypertension with systemic sclerosis: contribution to the transcriptional activity.
    Kawaguchi Y; Tochimoto A; Hara M; Kawamoto M; Sugiura T; Katsumata Y; Okada J; Kondo H; Okubo M; Kamatani N
    Arthritis Res Ther; 2006; 8(4):R104. PubMed ID: 16813666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymorphisms in the promoter region of iNOS predispose to rheumatoid arthritis in south Indian Tamils.
    Negi VS; Mariaselvam CM; Misra DP; Muralidharan N; Fortier C; Charron D; Krishnamoorthy R; Tamouza R
    Int J Immunogenet; 2017 Jun; 44(3):114-121. PubMed ID: 28374504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.